Global Moderate to Severe Plaque Psoriasis Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Moderate to Severe Plaque Psoriasis Medications market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The driving factors for moderate to severe plaque psoriasis drugs mainly include the following aspects:
Disease severity: Patients with moderate to severe plaque psoriasis have a more severe condition and require medication to control the progression of the disease and relieve symptoms. Therefore, there is a high demand for drugs for moderate to severe plaque psoriasis, which promotes the development and application of related drugs.
Medical needs: Psoriasis is a chronic, relapsing, inflammatory skin disease that requires long-term treatment and management. Therefore, the increase in medical demand has also promoted the development and application of drugs for moderate to severe plaque psoriasis.
Development of science and technology: With the continuous advancement of science and technology, new drugs and technical means are constantly emerging, providing more possibilities and opportunities for the development and application of drugs for moderate to severe plaque psoriasis. For example, new drug formulations, delivery methods, treatment methods, etc. can improve treatment effects and patient compliance.
Policy support: The government and regulatory agencies provide policy support for the research, development and application of innovative drugs and encourage pharmaceutical companies to conduct research and development. This also provides more opportunities and resources for the research, development and application of drugs for moderate to severe plaque psoriasis. .
Market demand: As the number of psoriasis patients continues to increase, the market demand is also growing. The demand from patients and doctors for drugs with better therapeutic effects has also driven the development and application of drugs for moderate to severe plaque psoriasis.
The Global Info Research report includes an overview of the development of the Moderate to Severe Plaque Psoriasis Medications industry chain, the market status of Hospital Clinic (Injection, Oral), Pharmacy (Injection, Oral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Moderate to Severe Plaque Psoriasis Medications.
Regionally, the report analyzes the Moderate to Severe Plaque Psoriasis Medications markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Moderate to Severe Plaque Psoriasis Medications market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Moderate to Severe Plaque Psoriasis Medications market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Moderate to Severe Plaque Psoriasis Medications industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Injection, Oral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Moderate to Severe Plaque Psoriasis Medications market.
Regional Analysis: The report involves examining the Moderate to Severe Plaque Psoriasis Medications market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Moderate to Severe Plaque Psoriasis Medications market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Moderate to Severe Plaque Psoriasis Medications:
Company Analysis: Report covers individual Moderate to Severe Plaque Psoriasis Medications manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Moderate to Severe Plaque Psoriasis Medications This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sales Channel (Hospital Clinic, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Moderate to Severe Plaque Psoriasis Medications. It assesses the current state, advancements, and potential future developments in Moderate to Severe Plaque Psoriasis Medications areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Moderate to Severe Plaque Psoriasis Medications market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Moderate to Severe Plaque Psoriasis Medications market is split by Type and by Sales Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value.
Market segment by Type
Chapter 1, to describe Moderate to Severe Plaque Psoriasis Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Moderate to Severe Plaque Psoriasis Medications, with price, sales, revenue and global market share of Moderate to Severe Plaque Psoriasis Medications from 2019 to 2024.
Chapter 3, the Moderate to Severe Plaque Psoriasis Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Moderate to Severe Plaque Psoriasis Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Moderate to Severe Plaque Psoriasis Medications market forecast, by regions, type and sales channel, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Moderate to Severe Plaque Psoriasis Medications.
Chapter 14 and 15, to describe Moderate to Severe Plaque Psoriasis Medications sales channel, distributors, customers, research findings and conclusion.
The driving factors for moderate to severe plaque psoriasis drugs mainly include the following aspects:
Disease severity: Patients with moderate to severe plaque psoriasis have a more severe condition and require medication to control the progression of the disease and relieve symptoms. Therefore, there is a high demand for drugs for moderate to severe plaque psoriasis, which promotes the development and application of related drugs.
Medical needs: Psoriasis is a chronic, relapsing, inflammatory skin disease that requires long-term treatment and management. Therefore, the increase in medical demand has also promoted the development and application of drugs for moderate to severe plaque psoriasis.
Development of science and technology: With the continuous advancement of science and technology, new drugs and technical means are constantly emerging, providing more possibilities and opportunities for the development and application of drugs for moderate to severe plaque psoriasis. For example, new drug formulations, delivery methods, treatment methods, etc. can improve treatment effects and patient compliance.
Policy support: The government and regulatory agencies provide policy support for the research, development and application of innovative drugs and encourage pharmaceutical companies to conduct research and development. This also provides more opportunities and resources for the research, development and application of drugs for moderate to severe plaque psoriasis. .
Market demand: As the number of psoriasis patients continues to increase, the market demand is also growing. The demand from patients and doctors for drugs with better therapeutic effects has also driven the development and application of drugs for moderate to severe plaque psoriasis.
The Global Info Research report includes an overview of the development of the Moderate to Severe Plaque Psoriasis Medications industry chain, the market status of Hospital Clinic (Injection, Oral), Pharmacy (Injection, Oral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Moderate to Severe Plaque Psoriasis Medications.
Regionally, the report analyzes the Moderate to Severe Plaque Psoriasis Medications markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Moderate to Severe Plaque Psoriasis Medications market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Moderate to Severe Plaque Psoriasis Medications market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Moderate to Severe Plaque Psoriasis Medications industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Injection, Oral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Moderate to Severe Plaque Psoriasis Medications market.
Regional Analysis: The report involves examining the Moderate to Severe Plaque Psoriasis Medications market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Moderate to Severe Plaque Psoriasis Medications market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Moderate to Severe Plaque Psoriasis Medications:
Company Analysis: Report covers individual Moderate to Severe Plaque Psoriasis Medications manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Moderate to Severe Plaque Psoriasis Medications This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sales Channel (Hospital Clinic, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Moderate to Severe Plaque Psoriasis Medications. It assesses the current state, advancements, and potential future developments in Moderate to Severe Plaque Psoriasis Medications areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Moderate to Severe Plaque Psoriasis Medications market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Moderate to Severe Plaque Psoriasis Medications market is split by Type and by Sales Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value.
Market segment by Type
- Injection
- Oral
- Topical Cream
- Hospital Clinic
- Pharmacy
- Online Shopping Mall
- Janssen Biotech
- Abbvie
- Sandoz
- Amgen
- Eli Lilly
- Novartis
- Sun Pharmaceutical Industries
- UCB, Inc
- Dermavant Sciences
- GSK
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Moderate to Severe Plaque Psoriasis Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Moderate to Severe Plaque Psoriasis Medications, with price, sales, revenue and global market share of Moderate to Severe Plaque Psoriasis Medications from 2019 to 2024.
Chapter 3, the Moderate to Severe Plaque Psoriasis Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Moderate to Severe Plaque Psoriasis Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Moderate to Severe Plaque Psoriasis Medications market forecast, by regions, type and sales channel, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Moderate to Severe Plaque Psoriasis Medications.
Chapter 14 and 15, to describe Moderate to Severe Plaque Psoriasis Medications sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Moderate to Severe Plaque Psoriasis Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Oral
1.3.4 Topical Cream
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Clinic
1.4.3 Pharmacy
1.4.4 Online Shopping Mall
1.5 Global Moderate to Severe Plaque Psoriasis Medications Market Size & Forecast
1.5.1 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity (2019-2030)
1.5.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Janssen Biotech
2.1.1 Janssen Biotech Details
2.1.2 Janssen Biotech Major Business
2.1.3 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Product and Services
2.1.4 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Janssen Biotech Recent Developments/Updates
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie Moderate to Severe Plaque Psoriasis Medications Product and Services
2.2.4 Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbvie Recent Developments/Updates
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Moderate to Severe Plaque Psoriasis Medications Product and Services
2.3.4 Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sandoz Recent Developments/Updates
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Moderate to Severe Plaque Psoriasis Medications Product and Services
2.4.4 Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amgen Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Product and Services
2.5.4 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Moderate to Severe Plaque Psoriasis Medications Product and Services
2.6.4 Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments/Updates
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Product and Services
2.7.4 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.8 UCB, Inc
2.8.1 UCB, Inc Details
2.8.2 UCB, Inc Major Business
2.8.3 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Product and Services
2.8.4 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 UCB, Inc Recent Developments/Updates
2.9 Dermavant Sciences
2.9.1 Dermavant Sciences Details
2.9.2 Dermavant Sciences Major Business
2.9.3 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Product and Services
2.9.4 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Dermavant Sciences Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Moderate to Severe Plaque Psoriasis Medications Product and Services
2.10.4 GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODERATE TO SEVERE PLAQUE PSORIASIS MEDICATIONS BY MANUFACTURER
3.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Manufacturer (2019-2024)
3.2 Global Moderate to Severe Plaque Psoriasis Medications Revenue by Manufacturer (2019-2024)
3.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Moderate to Severe Plaque Psoriasis Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Moderate to Severe Plaque Psoriasis Medications Manufacturer Market Share in 2023
3.4.2 Top 6 Moderate to Severe Plaque Psoriasis Medications Manufacturer Market Share in 2023
3.5 Moderate to Severe Plaque Psoriasis Medications Market: Overall Company Footprint Analysis
3.5.1 Moderate to Severe Plaque Psoriasis Medications Market: Region Footprint
3.5.2 Moderate to Severe Plaque Psoriasis Medications Market: Company Product Type Footprint
3.5.3 Moderate to Severe Plaque Psoriasis Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Moderate to Severe Plaque Psoriasis Medications Market Size by Region
4.1.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2030)
4.1.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2030)
4.1.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2019-2030)
4.2 North America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.3 Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.4 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.5 South America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.6 Middle East and Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
5.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2019-2030)
5.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2030)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
6.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2019-2030)
6.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2030)
7 NORTH AMERICA
7.1 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
7.2 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
7.3 North America Moderate to Severe Plaque Psoriasis Medications Market Size by Country
7.3.1 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
7.3.2 North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
8.2 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
8.3 Europe Moderate to Severe Plaque Psoriasis Medications Market Size by Country
8.3.1 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
8.3.2 Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
9.3 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Market Size by Region
9.3.1 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
10.2 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
10.3 South America Moderate to Severe Plaque Psoriasis Medications Market Size by Country
10.3.1 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
10.3.2 South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
11.3 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Market Size by Country
11.3.1 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Moderate to Severe Plaque Psoriasis Medications Market Drivers
12.2 Moderate to Severe Plaque Psoriasis Medications Market Restraints
12.3 Moderate to Severe Plaque Psoriasis Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Moderate to Severe Plaque Psoriasis Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Moderate to Severe Plaque Psoriasis Medications
13.3 Moderate to Severe Plaque Psoriasis Medications Production Process
13.4 Moderate to Severe Plaque Psoriasis Medications Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Moderate to Severe Plaque Psoriasis Medications Typical Distributors
14.3 Moderate to Severe Plaque Psoriasis Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Moderate to Severe Plaque Psoriasis Medications
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Oral
1.3.4 Topical Cream
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Clinic
1.4.3 Pharmacy
1.4.4 Online Shopping Mall
1.5 Global Moderate to Severe Plaque Psoriasis Medications Market Size & Forecast
1.5.1 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity (2019-2030)
1.5.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Janssen Biotech
2.1.1 Janssen Biotech Details
2.1.2 Janssen Biotech Major Business
2.1.3 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Product and Services
2.1.4 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Janssen Biotech Recent Developments/Updates
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie Moderate to Severe Plaque Psoriasis Medications Product and Services
2.2.4 Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbvie Recent Developments/Updates
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Moderate to Severe Plaque Psoriasis Medications Product and Services
2.3.4 Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sandoz Recent Developments/Updates
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Moderate to Severe Plaque Psoriasis Medications Product and Services
2.4.4 Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amgen Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Product and Services
2.5.4 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Moderate to Severe Plaque Psoriasis Medications Product and Services
2.6.4 Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments/Updates
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Product and Services
2.7.4 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.8 UCB, Inc
2.8.1 UCB, Inc Details
2.8.2 UCB, Inc Major Business
2.8.3 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Product and Services
2.8.4 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 UCB, Inc Recent Developments/Updates
2.9 Dermavant Sciences
2.9.1 Dermavant Sciences Details
2.9.2 Dermavant Sciences Major Business
2.9.3 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Product and Services
2.9.4 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Dermavant Sciences Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Moderate to Severe Plaque Psoriasis Medications Product and Services
2.10.4 GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODERATE TO SEVERE PLAQUE PSORIASIS MEDICATIONS BY MANUFACTURER
3.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Manufacturer (2019-2024)
3.2 Global Moderate to Severe Plaque Psoriasis Medications Revenue by Manufacturer (2019-2024)
3.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Moderate to Severe Plaque Psoriasis Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Moderate to Severe Plaque Psoriasis Medications Manufacturer Market Share in 2023
3.4.2 Top 6 Moderate to Severe Plaque Psoriasis Medications Manufacturer Market Share in 2023
3.5 Moderate to Severe Plaque Psoriasis Medications Market: Overall Company Footprint Analysis
3.5.1 Moderate to Severe Plaque Psoriasis Medications Market: Region Footprint
3.5.2 Moderate to Severe Plaque Psoriasis Medications Market: Company Product Type Footprint
3.5.3 Moderate to Severe Plaque Psoriasis Medications Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Moderate to Severe Plaque Psoriasis Medications Market Size by Region
4.1.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2030)
4.1.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2030)
4.1.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2019-2030)
4.2 North America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.3 Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.4 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.5 South America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
4.6 Middle East and Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
5.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2019-2030)
5.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2030)
6 MARKET SEGMENT BY SALES CHANNEL
6.1 Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
6.2 Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2019-2030)
6.3 Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2030)
7 NORTH AMERICA
7.1 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
7.2 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
7.3 North America Moderate to Severe Plaque Psoriasis Medications Market Size by Country
7.3.1 North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
7.3.2 North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
8.2 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
8.3 Europe Moderate to Severe Plaque Psoriasis Medications Market Size by Country
8.3.1 Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
8.3.2 Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
9.3 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Market Size by Region
9.3.1 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
10.2 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
10.3 South America Moderate to Severe Plaque Psoriasis Medications Market Size by Country
10.3.1 South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
10.3.2 South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2030)
11.3 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Market Size by Country
11.3.1 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Moderate to Severe Plaque Psoriasis Medications Market Drivers
12.2 Moderate to Severe Plaque Psoriasis Medications Market Restraints
12.3 Moderate to Severe Plaque Psoriasis Medications Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Moderate to Severe Plaque Psoriasis Medications and Key Manufacturers
13.2 Manufacturing Costs Percentage of Moderate to Severe Plaque Psoriasis Medications
13.3 Moderate to Severe Plaque Psoriasis Medications Production Process
13.4 Moderate to Severe Plaque Psoriasis Medications Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Moderate to Severe Plaque Psoriasis Medications Typical Distributors
14.3 Moderate to Severe Plaque Psoriasis Medications Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Biotech Major Business
Table 5. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 6. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Janssen Biotech Recent Developments/Updates
Table 8. Abbvie Basic Information, Manufacturing Base and Competitors
Table 9. Abbvie Major Business
Table 10. Abbvie Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 11. Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Abbvie Recent Developments/Updates
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Major Business
Table 15. Sandoz Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 16. Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sandoz Recent Developments/Updates
Table 18. Amgen Basic Information, Manufacturing Base and Competitors
Table 19. Amgen Major Business
Table 20. Amgen Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 21. Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Amgen Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 26. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 31. Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Novartis Recent Developments/Updates
Table 33. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Industries Major Business
Table 35. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 36. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sun Pharmaceutical Industries Recent Developments/Updates
Table 38. UCB, Inc Basic Information, Manufacturing Base and Competitors
Table 39. UCB, Inc Major Business
Table 40. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 41. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. UCB, Inc Recent Developments/Updates
Table 43. Dermavant Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Dermavant Sciences Major Business
Table 45. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 46. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Dermavant Sciences Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 51. GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Moderate to Severe Plaque Psoriasis Medications Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Moderate to Severe Plaque Psoriasis Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Moderate to Severe Plaque Psoriasis Medications Production Site of Key Manufacturer
Table 58. Moderate to Severe Plaque Psoriasis Medications Market: Company Product Type Footprint
Table 59. Moderate to Severe Plaque Psoriasis Medications Market: Company Product Application Footprint
Table 60. Moderate to Severe Plaque Psoriasis Medications New Market Entrants and Barriers to Market Entry
Table 61. Moderate to Severe Plaque Psoriasis Medications Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 75. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 76. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2019-2024) & (USD Million)
Table 77. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2025-2030) & (USD Million)
Table 78. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2024) & (US$/Unit)
Table 79. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2025-2030) & (US$/Unit)
Table 80. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 83. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 84. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 91. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 92. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 99. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 100. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 107. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 108. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 115. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 116. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Moderate to Severe Plaque Psoriasis Medications Raw Material
Table 121. Key Manufacturers of Moderate to Severe Plaque Psoriasis Medications Raw Materials
Table 122. Moderate to Severe Plaque Psoriasis Medications Typical Distributors
Table 123. Moderate to Severe Plaque Psoriasis Medications Typical Customers
Table 1. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Biotech Major Business
Table 5. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 6. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Janssen Biotech Recent Developments/Updates
Table 8. Abbvie Basic Information, Manufacturing Base and Competitors
Table 9. Abbvie Major Business
Table 10. Abbvie Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 11. Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Abbvie Recent Developments/Updates
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Major Business
Table 15. Sandoz Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 16. Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sandoz Recent Developments/Updates
Table 18. Amgen Basic Information, Manufacturing Base and Competitors
Table 19. Amgen Major Business
Table 20. Amgen Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 21. Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Amgen Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 26. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 31. Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Novartis Recent Developments/Updates
Table 33. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Industries Major Business
Table 35. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 36. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sun Pharmaceutical Industries Recent Developments/Updates
Table 38. UCB, Inc Basic Information, Manufacturing Base and Competitors
Table 39. UCB, Inc Major Business
Table 40. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 41. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. UCB, Inc Recent Developments/Updates
Table 43. Dermavant Sciences Basic Information, Manufacturing Base and Competitors
Table 44. Dermavant Sciences Major Business
Table 45. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 46. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Dermavant Sciences Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Moderate to Severe Plaque Psoriasis Medications Product and Services
Table 51. GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Moderate to Severe Plaque Psoriasis Medications Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Moderate to Severe Plaque Psoriasis Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Moderate to Severe Plaque Psoriasis Medications Production Site of Key Manufacturer
Table 58. Moderate to Severe Plaque Psoriasis Medications Market: Company Product Type Footprint
Table 59. Moderate to Severe Plaque Psoriasis Medications Market: Company Product Application Footprint
Table 60. Moderate to Severe Plaque Psoriasis Medications New Market Entrants and Barriers to Market Entry
Table 61. Moderate to Severe Plaque Psoriasis Medications Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 75. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 76. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2019-2024) & (USD Million)
Table 77. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel (2025-2030) & (USD Million)
Table 78. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2024) & (US$/Unit)
Table 79. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2025-2030) & (US$/Unit)
Table 80. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 83. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 84. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 91. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 92. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 99. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 100. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 107. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 108. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2019-2024) & (K Units)
Table 115. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Sales Channel (2025-2030) & (K Units)
Table 116. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Moderate to Severe Plaque Psoriasis Medications Raw Material
Table 121. Key Manufacturers of Moderate to Severe Plaque Psoriasis Medications Raw Materials
Table 122. Moderate to Severe Plaque Psoriasis Medications Typical Distributors
Table 123. Moderate to Severe Plaque Psoriasis Medications Typical Customers
LIST OF FIGURES
Figure 1. Moderate to Severe Plaque Psoriasis Medications Picture
Figure 2. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Type in 2023
Figure 4. Injection Examples
Figure 5. Oral Examples
Figure 6. Topical Cream Examples
Figure 7. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Sales Channel in 2023
Figure 9. Hospital Clinic Examples
Figure 10. Pharmacy Examples
Figure 11. Online Shopping Mall Examples
Figure 12. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Moderate to Severe Plaque Psoriasis Medications Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Moderate to Severe Plaque Psoriasis Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Moderate to Severe Plaque Psoriasis Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Moderate to Severe Plaque Psoriasis Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 32. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Sales Channel (2019-2030)
Figure 33. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2030) & (US$/Unit)
Figure 34. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 36. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 43. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 52. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 54. China Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 62. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 68. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Moderate to Severe Plaque Psoriasis Medications Market Drivers
Figure 75. Moderate to Severe Plaque Psoriasis Medications Market Restraints
Figure 76. Moderate to Severe Plaque Psoriasis Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Moderate to Severe Plaque Psoriasis Medications in 2023
Figure 79. Manufacturing Process Analysis of Moderate to Severe Plaque Psoriasis Medications
Figure 80. Moderate to Severe Plaque Psoriasis Medications Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Moderate to Severe Plaque Psoriasis Medications Picture
Figure 2. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Type in 2023
Figure 4. Injection Examples
Figure 5. Oral Examples
Figure 6. Topical Cream Examples
Figure 7. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Sales Channel in 2023
Figure 9. Hospital Clinic Examples
Figure 10. Pharmacy Examples
Figure 11. Online Shopping Mall Examples
Figure 12. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Moderate to Severe Plaque Psoriasis Medications Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Moderate to Severe Plaque Psoriasis Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Moderate to Severe Plaque Psoriasis Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Moderate to Severe Plaque Psoriasis Medications Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 32. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Sales Channel (2019-2030)
Figure 33. Global Moderate to Severe Plaque Psoriasis Medications Average Price by Sales Channel (2019-2030) & (US$/Unit)
Figure 34. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 36. North America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 43. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 52. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 54. China Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 62. South America Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Sales Channel (2019-2030)
Figure 68. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Moderate to Severe Plaque Psoriasis Medications Market Drivers
Figure 75. Moderate to Severe Plaque Psoriasis Medications Market Restraints
Figure 76. Moderate to Severe Plaque Psoriasis Medications Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Moderate to Severe Plaque Psoriasis Medications in 2023
Figure 79. Manufacturing Process Analysis of Moderate to Severe Plaque Psoriasis Medications
Figure 80. Moderate to Severe Plaque Psoriasis Medications Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
